Report on stage III Pig-a mutation assays using N-ethyl-N-nitrosourea - comparison with other in vivo genotoxicity endpoints
N‐Ethyl‐N‐nitrosourea (ENU) was evaluated as part of the Stage III trial for the rat Pig‐a gene mutation assay. Groups of six‐ to eight‐week‐old male Sprague Dawley (SD) or Fischer 344 (F344) rats were given 28 daily doses of the phosphate buffered saline vehicle, or 2.5, 5, or 10 mg/kg ENU, and eva...
Saved in:
Published in | Environmental and molecular mutagenesis Vol. 52; no. 9; pp. 721 - 730 |
---|---|
Main Authors | , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Hoboken
Wiley Subscription Services, Inc., A Wiley Company
01.12.2011
Wiley-Liss |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | N‐Ethyl‐N‐nitrosourea (ENU) was evaluated as part of the Stage III trial for the rat Pig‐a gene mutation assay. Groups of six‐ to eight‐week‐old male Sprague Dawley (SD) or Fischer 344 (F344) rats were given 28 daily doses of the phosphate buffered saline vehicle, or 2.5, 5, or 10 mg/kg ENU, and evaluated for a variety of genotoxicity endpoints in peripheral blood, spleen, liver, and colon. Blood was sampled predose (Day‐1) and at various time points up to Day 57. Pig‐a mutant frequencies were determined in total red blood cells (RBCs) and reticulocytes (RETs) as RBCCD59− and RETCD59− frequencies. Consistent with the results from a reference laboratory, RBCCD59− and RETCD59− frequencies increased in a dose‐ and time‐dependent manner, producing significant increases at all doses by Day 15, with similar frequencies seen in both rat strains. ENU also induced small but significant increases in % micronucleated RETs on Days 4 and 29. No significant increases in micronuclei were seen in the liver or colon of the ENU‐treated SD rats. Hprt and Pig‐a lymphocyte mutation assays conducted on splenocytes from Day 56 F344 rats detected two‐ to fourfold stronger responses for Hprt than Pig‐a mutations. Results from the in vivo Comet assay in SD rats at Day 29 showed generally weak increases in DNA damage in all tissues evaluated. The results with ENU indicate that the Pig‐a RET and RBC assays are reproducible, transferable, and complement other genotoxicity endpoints that could potentially be integrated into 28‐day repeat‐dose rat studies. © Environ. Mol. Mutagen. 2011. Published 2011 Wiley‐Liss, Inc. |
---|---|
AbstractList | N
‐Ethyl‐
N
‐nitrosourea (ENU) was evaluated as part of the Stage III trial for the rat
Pig‐a
gene mutation assay. Groups of six‐ to eight‐week‐old male Sprague Dawley (SD) or Fischer 344 (F344) rats were given 28 daily doses of the phosphate buffered saline vehicle, or 2.5, 5, or 10 mg/kg ENU, and evaluated for a variety of genotoxicity endpoints in peripheral blood, spleen, liver, and colon. Blood was sampled predose (Day‐1) and at various time points up to Day 57.
Pig‐a
mutant frequencies were determined in total red blood cells (RBCs) and reticulocytes (RETs) as RBC
CD59−
and RET
CD59−
frequencies. Consistent with the results from a reference laboratory, RBC
CD59−
and RET
CD59−
frequencies increased in a dose‐ and time‐dependent manner, producing significant increases at all doses by Day 15, with similar frequencies seen in both rat strains. ENU also induced small but significant increases in % micronucleated RETs on Days 4 and 29. No significant increases in micronuclei were seen in the liver or colon of the ENU‐treated SD rats.
Hprt
and
Pig‐a
lymphocyte mutation assays conducted on splenocytes from Day 56 F344 rats detected two‐ to fourfold stronger responses for
Hprt
than
Pig‐a
mutations. Results from the in vivo Comet assay in SD rats at Day 29 showed generally weak increases in DNA damage in all tissues evaluated. The results with ENU indicate that the
Pig‐a
RET and RBC assays are reproducible, transferable, and complement other genotoxicity endpoints that could potentially be integrated into 28‐day repeat‐dose rat studies. © Environ. Mol. Mutagen. 2011. Published 2011 Wiley‐Liss, Inc. N-Ethyl-N-nitrosourea (ENU) was evaluated as part of the Stage III trial for the rat Pig-a gene mutation assay. Groups of six- to eight-week-old male Sprague Dawley (SD) or Fischer 344 (F344) rats were given 28 daily doses of the phosphate buffered saline vehicle, or 2.5, 5, or 10 mg/kg ENU, and evaluated for a variety of genotoxicity endpoints in peripheral blood, spleen, liver, and colon. Blood was sampled predose (Day-1) and at various time points up to Day 57. Pig-a mutant frequencies were determined in total red blood cells (RBCs) and reticulocytes (RETs) as RBC(CD592-) and RET(CD592-) frequencies. Consistent with the results from a reference laboratory, RBC(CD592-) and RET(CD592-) frequencies increased in a dose and time-dependent manner, producing significant increases at all doses by Day 15, with similar frequencies seen in both rat strains. ENU also induced small but significant increases in % micronucleated RETs on Days 4 and 29. No significant increases in micronuclei were seen in the liver or colon of the ENU-treated SD rats. Hprt and Pig-a lymphocyte mutation assays conducted on splenocytes from Day 56 F344 rats detected two- to fourfold stronger responses for Hprt than Pig-a mutations. Results from the in vivo Comet assay in SD rats at Day 29 showed generally weak increases in DNA damage in all tissues evaluated. The results with ENU indicate that the Pig-a RET and RBC assays are reproducible, transferable, and complement other genotoxicity endpoints that could potentially be integrated into 28-day repeat dose rat studies. N‐Ethyl‐N‐nitrosourea (ENU) was evaluated as part of the Stage III trial for the rat Pig‐a gene mutation assay. Groups of six‐ to eight‐week‐old male Sprague Dawley (SD) or Fischer 344 (F344) rats were given 28 daily doses of the phosphate buffered saline vehicle, or 2.5, 5, or 10 mg/kg ENU, and evaluated for a variety of genotoxicity endpoints in peripheral blood, spleen, liver, and colon. Blood was sampled predose (Day‐1) and at various time points up to Day 57. Pig‐a mutant frequencies were determined in total red blood cells (RBCs) and reticulocytes (RETs) as RBCCD59− and RETCD59− frequencies. Consistent with the results from a reference laboratory, RBCCD59− and RETCD59− frequencies increased in a dose‐ and time‐dependent manner, producing significant increases at all doses by Day 15, with similar frequencies seen in both rat strains. ENU also induced small but significant increases in % micronucleated RETs on Days 4 and 29. No significant increases in micronuclei were seen in the liver or colon of the ENU‐treated SD rats. Hprt and Pig‐a lymphocyte mutation assays conducted on splenocytes from Day 56 F344 rats detected two‐ to fourfold stronger responses for Hprt than Pig‐a mutations. Results from the in vivo Comet assay in SD rats at Day 29 showed generally weak increases in DNA damage in all tissues evaluated. The results with ENU indicate that the Pig‐a RET and RBC assays are reproducible, transferable, and complement other genotoxicity endpoints that could potentially be integrated into 28‐day repeat‐dose rat studies. © Environ. Mol. Mutagen. 2011. Published 2011 Wiley‐Liss, Inc. N-Ethyl-N-nitrosourea (ENU) was evaluated as part of the Stage III trial for the rat Pig-a gene mutation assay. Groups of six- to eight-week-old male Sprague Dawley (SD) or Fischer 344 (F344) rats were given 28 daily doses of the phosphate buffered saline vehicle, or 2.5, 5, or 10 mg/kg ENU, and evaluated for a variety of genotoxicity endpoints in peripheral blood, spleen, liver, and colon. Blood was sampled predose (Day-1) and at various time points up to Day 57. Pig-a mutant frequencies were determined in total red blood cells (RBCs) and reticulocytes (RETs) as RBCCD59- and RETCD59- frequencies. Consistent with the results from a reference laboratory, RBCCD59- and RETCD59- frequencies increased in a dose- and time-dependent manner, producing significant increases at all doses by Day 15, with similar frequencies seen in both rat strains. ENU also induced small but significant increases in % micronucleated RETs on Days 4 and 29. No significant increases in micronuclei were seen in the liver or colon of the ENU-treated SD rats. Hprt and Pig-a lymphocyte mutation assays conducted on splenocytes from Day 56 F344 rats detected two- to fourfold stronger responses for Hprt than Pig-a mutations. Results from the in vivo Comet assay in SD rats at Day 29 showed generally weak increases in DNA damage in all tissues evaluated. The results with ENU indicate that the Pig-a RET and RBC assays are reproducible, transferable, and complement other genotoxicity endpoints that could potentially be integrated into 28-day repeat-dose rat studies. ? Environ. Mol. Mutagen. 2011. Published 2011 Wiley-Liss, Inc. N-Ethyl-N-nitrosourea (ENU) was evaluated as part of the Stage III trial for the rat Pig-a gene mutation assay. Groups of six- to eight-week-old male Sprague Dawley (SD) or Fischer 344 (F344) rats were given 28 daily doses of the phosphate buffered saline vehicle, or 2.5, 5, or 10 mg/kg ENU, and evaluated for a variety of genotoxicity endpoints in peripheral blood, spleen, liver, and colon. Blood was sampled predose (Day-1) and at various time points up to Day 57. Pig-a mutant frequencies were determined in total red blood cells (RBCs) and reticulocytes (RETs) as RBC(CD592-) and RET(CD592-) frequencies. Consistent with the results from a reference laboratory, RBC(CD592-) and RET(CD592-) frequencies increased in a dose and time-dependent manner, producing significant increases at all doses by Day 15, with similar frequencies seen in both rat strains. ENU also induced small but significant increases in % micronucleated RETs on Days 4 and 29. No significant increases in micronuclei were seen in the liver or colon of the ENU-treated SD rats. Hprt and Pig-a lymphocyte mutation assays conducted on splenocytes from Day 56 F344 rats detected two- to fourfold stronger responses for Hprt than Pig-a mutations. Results from the in vivo Comet assay in SD rats at Day 29 showed generally weak increases in DNA damage in all tissues evaluated. The results with ENU indicate that the Pig-a RET and RBC assays are reproducible, transferable, and complement other genotoxicity endpoints that could potentially be integrated into 28-day repeat dose rat studies.N-Ethyl-N-nitrosourea (ENU) was evaluated as part of the Stage III trial for the rat Pig-a gene mutation assay. Groups of six- to eight-week-old male Sprague Dawley (SD) or Fischer 344 (F344) rats were given 28 daily doses of the phosphate buffered saline vehicle, or 2.5, 5, or 10 mg/kg ENU, and evaluated for a variety of genotoxicity endpoints in peripheral blood, spleen, liver, and colon. Blood was sampled predose (Day-1) and at various time points up to Day 57. Pig-a mutant frequencies were determined in total red blood cells (RBCs) and reticulocytes (RETs) as RBC(CD592-) and RET(CD592-) frequencies. Consistent with the results from a reference laboratory, RBC(CD592-) and RET(CD592-) frequencies increased in a dose and time-dependent manner, producing significant increases at all doses by Day 15, with similar frequencies seen in both rat strains. ENU also induced small but significant increases in % micronucleated RETs on Days 4 and 29. No significant increases in micronuclei were seen in the liver or colon of the ENU-treated SD rats. Hprt and Pig-a lymphocyte mutation assays conducted on splenocytes from Day 56 F344 rats detected two- to fourfold stronger responses for Hprt than Pig-a mutations. Results from the in vivo Comet assay in SD rats at Day 29 showed generally weak increases in DNA damage in all tissues evaluated. The results with ENU indicate that the Pig-a RET and RBC assays are reproducible, transferable, and complement other genotoxicity endpoints that could potentially be integrated into 28-day repeat dose rat studies. |
Author | Shutsky, Thomas Pearce, Mason G. Thiffeault, Catherine J. Gunther, William C. Cao, Xuefei Dobrovolsky, Vasily N. Heflich, Robert H. Dickinson, Donna Dobo, Krista L. Engel, Maria Shaddock, Joseph G. Bhalli, Javed A. Fiedler, Ronald D. Schuler, Maik Coffing, Stephanie L. Cammerer, Zoryana |
Author_xml | – sequence: 1 givenname: Zoryana surname: Cammerer fullname: Cammerer, Zoryana organization: Pfizer Global Research and Development, Genetic Toxicology Center of Emphasis, Groton, Connecticut 06350 – sequence: 2 givenname: Javed A. surname: Bhalli fullname: Bhalli, Javed A. organization: Division of Genetic and Molecular Toxicology, U.S. Food and Drug Administration/National Center for Toxicological Research, Jefferson, Arkansas 72079 – sequence: 3 givenname: Xuefei surname: Cao fullname: Cao, Xuefei organization: Division of Genetic and Molecular Toxicology, U.S. Food and Drug Administration/National Center for Toxicological Research, Jefferson, Arkansas 72079 – sequence: 4 givenname: Stephanie L. surname: Coffing fullname: Coffing, Stephanie L. organization: Pfizer Global Research and Development, Genetic Toxicology Center of Emphasis, Groton, Connecticut 06350 – sequence: 5 givenname: Donna surname: Dickinson fullname: Dickinson, Donna organization: Pfizer Global Research and Development, Genetic Toxicology Center of Emphasis, Groton, Connecticut 06350 – sequence: 6 givenname: Krista L. surname: Dobo fullname: Dobo, Krista L. organization: Pfizer Global Research and Development, Genetic Toxicology Center of Emphasis, Groton, Connecticut 06350 – sequence: 7 givenname: Vasily N. surname: Dobrovolsky fullname: Dobrovolsky, Vasily N. organization: Division of Genetic and Molecular Toxicology, U.S. Food and Drug Administration/National Center for Toxicological Research, Jefferson, Arkansas 72079 – sequence: 8 givenname: Maria surname: Engel fullname: Engel, Maria organization: Pfizer Global Research and Development, Genetic Toxicology Center of Emphasis, Groton, Connecticut 06350 – sequence: 9 givenname: Ronald D. surname: Fiedler fullname: Fiedler, Ronald D. organization: Pfizer Global Research and Development, Genetic Toxicology Center of Emphasis, Groton, Connecticut 06350 – sequence: 10 givenname: William C. surname: Gunther fullname: Gunther, William C. organization: Pfizer Global Research and Development, Genetic Toxicology Center of Emphasis, Groton, Connecticut 06350 – sequence: 11 givenname: Robert H. surname: Heflich fullname: Heflich, Robert H. organization: Division of Genetic and Molecular Toxicology, U.S. Food and Drug Administration/National Center for Toxicological Research, Jefferson, Arkansas 72079 – sequence: 12 givenname: Mason G. surname: Pearce fullname: Pearce, Mason G. organization: Division of Genetic and Molecular Toxicology, U.S. Food and Drug Administration/National Center for Toxicological Research, Jefferson, Arkansas 72079 – sequence: 13 givenname: Joseph G. surname: Shaddock fullname: Shaddock, Joseph G. organization: Division of Genetic and Molecular Toxicology, U.S. Food and Drug Administration/National Center for Toxicological Research, Jefferson, Arkansas 72079 – sequence: 14 givenname: Thomas surname: Shutsky fullname: Shutsky, Thomas organization: Pfizer Global Research and Development, Genetic Toxicology Center of Emphasis, Groton, Connecticut 06350 – sequence: 15 givenname: Catherine J. surname: Thiffeault fullname: Thiffeault, Catherine J. organization: Pfizer Global Research and Development, Genetic Toxicology Center of Emphasis, Groton, Connecticut 06350 – sequence: 16 givenname: Maik surname: Schuler fullname: Schuler, Maik email: maik.schuler@pfizer.com organization: Pfizer Global Research and Development, Genetic Toxicology Center of Emphasis, Groton, Connecticut 06350 |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=25245702$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/22167886$$D View this record in MEDLINE/PubMed |
BookMark | eNp90U1v0zAYB3ALDbGuIPEJkC8ILi5-SRz7yKYxKo2C0Hi5WU7itIbELrazLRIfHrN2m4SAkw_--f9Y_-cIHDjvDABPCV4QjOkrMywo5oI_ADOCpUCUCnwAZlhIhjiX9BAcxfgNY0IKSR-BQ0oJr4TgM_Dzo9n6kKB3MCa9NnC5XMIPdo00HMakk80XOkY9RThG69ZwhUzaTD1aIWdT8NGPwWiIYOOHrQ42Zn9l0wb6tDEBWgcv7aWHa-N88te2sWmCxrVbb12Kj8HDTvfRPNmfc_DpzenFyVt0_v5sefL6HDVF_iiqWtky0bKaNQXHklScaInLGneMFrTFApNSNrwuC1loKg0hVBQ1pbqUXVe3FZuDF7vcbfA_RhOTGmxsTN9rZ_wYlSREspJQnuXL_0qCc7M0jy0zfbanYz2YVm2DHXSY1G23GTzfAx0b3XdBu8bGe1fmlCqHzcFi55pcZwymU7mlm-ZT0LbPM9XvJSszqJsl33_y7sFt5l8o2tEr25vpn06dvvvD25jM9Z3X4bviFatK9WV1poqv1TEVn5m6YL8AZ6zCKw |
CODEN | EMMUEG |
CitedBy_id | crossref_primary_10_1002_em_22232 crossref_primary_10_1002_em_20692 crossref_primary_10_1002_em_21981 crossref_primary_10_1002_em_22211 crossref_primary_10_1002_em_21862 crossref_primary_10_1093_mutage_gev077 crossref_primary_10_1002_em_20675 crossref_primary_10_1002_em_21863 crossref_primary_10_1016_j_fct_2018_10_061 crossref_primary_10_1093_mutage_gev013 crossref_primary_10_1002_em_21724 crossref_primary_10_1002_em_21825 crossref_primary_10_1002_em_21924 crossref_primary_10_1002_em_21709 crossref_primary_10_1016_j_mrgentox_2014_12_001 crossref_primary_10_3123_jemsge_2014_027 crossref_primary_10_1002_em_22060 crossref_primary_10_3123_jemsge_2014_023 crossref_primary_10_1016_j_mrgentox_2013_03_002 crossref_primary_10_1093_mutage_geu051 crossref_primary_10_1002_em_20685 crossref_primary_10_1093_mutage_geu055 crossref_primary_10_1007_s00204_018_2157_4 crossref_primary_10_1093_mutage_get022 crossref_primary_10_1002_em_21910 crossref_primary_10_1093_mutage_gew059 crossref_primary_10_1016_j_mrgentox_2016_10_003 crossref_primary_10_1093_mutage_gev005 crossref_primary_10_1002_em_22109 crossref_primary_10_1016_j_mrgentox_2015_12_005 crossref_primary_10_1007_s00204_014_1413_5 crossref_primary_10_1002_em_21818 crossref_primary_10_1016_j_mrgentox_2014_09_007 crossref_primary_10_2131_jts_37_943 crossref_primary_10_1093_toxsci_kfs258 |
Cites_doi | 10.1016/j.toxlet.2009.04.003 10.1016/j.mrgentox.2010.02.009 10.1016/j.toxlet.2009.03.021 10.1016/j.mrgentox.2011.06.005 10.1093/toxsci/kfp289 10.1016/j.mrgentox.2011.02.009 10.1002/em.20379 10.1002/em.20413 10.1158/0008-5472.CAN-06-4061 10.1159/000077506 10.1093/mutage/gen015 10.1016/S1383-5718(97)00144-7 10.1002/em.20675 10.1016/j.mrgentox.2009.05.014 10.2307/2530051 10.1016/S0027-5107(00)00065-8 10.1002/em.20616 10.1016/j.toxlet.2009.03.008 10.1093/toxsci/kfq070 |
ContentType | Journal Article |
Copyright | Copyright © 2011 Wiley‐Liss, Inc. 2015 INIST-CNRS |
Copyright_xml | – notice: Copyright © 2011 Wiley‐Liss, Inc. – notice: 2015 INIST-CNRS |
DBID | BSCLL AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7U7 8FD C1K FR3 P64 RC3 7X8 |
DOI | 10.1002/em.20686 |
DatabaseName | Istex CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Toxicology Abstracts Technology Research Database Environmental Sciences and Pollution Management Engineering Research Database Biotechnology and BioEngineering Abstracts Genetics Abstracts MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Genetics Abstracts Engineering Research Database Technology Research Database Toxicology Abstracts Biotechnology and BioEngineering Abstracts Environmental Sciences and Pollution Management MEDLINE - Academic |
DatabaseTitleList | CrossRef MEDLINE Genetics Abstracts MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
EISSN | 1098-2280 |
EndPage | 730 |
ExternalDocumentID | 22167886 25245702 10_1002_em_20686 EM20686 ark_67375_WNG_4X7B28V3_T |
Genre | article Comparative Study Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
GrantInformation_xml | – fundername: NIH‐NIEHS funderid: R44ES015940 – fundername: Oak Ridge Institute for Science and Education – fundername: NIEHS NIH HHS grantid: R44ES015940 |
GroupedDBID | --- .3N .GA .Y3 05W 0R~ 10A 1L6 1OB 1OC 1ZS 31~ 33P 3SF 3WU 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 A8Z AAESR AAEVG AAHHS AAIKC AAMNW AANLZ AAONW AASGY AAXRX AAZKR ABCQN ABCUV ABEFU ABEML ABIJN ABJNI ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACGFS ACGOF ACMXC ACPOU ACPRK ACSCC ACXBN ACXQS ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADOZA ADXAS ADZMN ADZOD AEEZP AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFFPM AFGKR AFPWT AFRAH AFZJQ AHBTC AI. AIACR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BSCLL BY8 C45 CS3 D-6 D-7 D-E D-F DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DU5 DUUFO EBD EBS EDH EJD EMOBN ESTFP F00 F01 F04 F5P FEDTE FUBAC G-S G.N GNP GODZA H.X HBH HF~ HGLYW HHY HHZ HVGLF HZ~ IX1 J0M JPC KBYEO KQQ LATKE LAW LC2 LC3 LEEKS LITHE LOXES LP6 LP7 LUTES LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ NNB O66 O9- OIG OVD P2P P2W P2X P2Z P4B P4D PALCI PQQKQ Q.N Q11 QB0 QRW R.K RIWAO RJQFR ROL RWI RX1 SAMSI SUPJJ SV3 TEORI TN5 UB1 V2E VH1 W8V W99 WBKPD WIB WIH WIJ WIK WJL WNSPC WOHZO WQJ WRC WUP WWO WXI WXSBR WYISQ XG1 XV2 ZGI ZXP ZZTAW ~IA ~KM ~WT - 0R 31 3N AAPBV AAVGM ABFLS ABHUG ACXME ADAWD ADDAD AFVGU AGJLS GA HZ IA IPNFZ KM NF P4A PQEST RIG WT Y3 AAHQN AAIPD AAMNL AANHP AAYCA AAYXX ACRPL ACYXJ ADNMO AEYWJ AFWVQ AGHNM AGQPQ AGYGG ALVPJ CITATION AAMMB AEFGJ AGXDD AIDQK AIDYY IQODW CGR CUY CVF ECM EIF NPM 7U7 8FD C1K FR3 P64 RC3 7X8 |
ID | FETCH-LOGICAL-c4216-7d9d38d3b3c46091761a905b0f3242d080159c6b5494a29e11284b22a59ffbd73 |
IEDL.DBID | DR2 |
ISSN | 0893-6692 1098-2280 |
IngestDate | Thu Jul 10 18:29:46 EDT 2025 Fri Jul 11 05:20:08 EDT 2025 Mon Jul 21 06:02:03 EDT 2025 Mon Jul 21 09:14:46 EDT 2025 Tue Jul 01 01:44:45 EDT 2025 Thu Apr 24 23:07:56 EDT 2025 Fri Jun 04 19:44:38 EDT 2021 Wed Oct 30 09:56:29 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 9 |
Keywords | Flow cytometry Rat Toxicity Nitrosoureas Glycosyltransferases Genotoxicity Hprt Hypoxanthine phosphoribosyltransferase Comet assay micronucleus assay Gene Micronucleus CD59 rats Ungulata Enzyme Report Mutagenicity testing Transferases gene mutation Rodentia reticulocytes Pig In vivo Vertebrata Mammalia Reticulocyte Artiodactyla Mutation Pentosyltransferases |
Language | English |
License | http://onlinelibrary.wiley.com/termsAndConditions#vor CC BY 4.0 |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c4216-7d9d38d3b3c46091761a905b0f3242d080159c6b5494a29e11284b22a59ffbd73 |
Notes | NIH-NIEHS - No. R44ES015940 Oak Ridge Institute for Science and Education ArticleID:EM20686 istex:249B1734DD0E3FA20018DA1FC76C6A9FED3F431D ark:/67375/WNG-4X7B28V3-T ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Article-2 ObjectType-Feature-1 |
PMID | 22167886 |
PQID | 1028023245 |
PQPubID | 23462 |
PageCount | 10 |
ParticipantIDs | proquest_miscellaneous_911935126 proquest_miscellaneous_1028023245 pubmed_primary_22167886 pascalfrancis_primary_25245702 crossref_citationtrail_10_1002_em_20686 crossref_primary_10_1002_em_20686 wiley_primary_10_1002_em_20686_EM20686 istex_primary_ark_67375_WNG_4X7B28V3_T |
ProviderPackageCode | 10A A01 RJQFR A03 ADOZA BFHJK DRMAN BROTX AMBMR DCZOG MRMAN ~IA ACAHQ LEEKS AFGKR 50Y 50Z AEUQT XG1 AAEVG MRSTM ACMXC .3N MEWTI 1ZS AAVGM Q11 LP7 H.X LP6 WUP 51W 51X ACXME WBKPD QB0 ADMGS UB1 AEIMD GNP ATUGU DUUFO WOHZO G-S KBYEO O66 AZBYB 52M 3WU 52N 52O 52P ADEOM LATKE ZZTAW 52R 52S 930 BAFTC 52T MK4 QRW SUPJJ 52U HHY 52V 52W DRSTM 1L6 52X HHZ AFPWT ALAGY DR2 G.N ACPOU AFZJQ WWO ADAWD 702 7PT 66C NNB ADIZJ .GA WXI AAONW LYRES GODZA HBH LUTES ALUQN AAZKR MSFUL LC2 AIURR LC3 AZVAB WNSPC RWI PALCI ABHUG KQQ RX1 ACXQS BMXJE R.K WIB WQJ MXFUL P2W W8V W99 WYISQ FUBAC MSMAN P2X WIH WIK P2Z WIJ JPC BDRZF BY8 MSSTM DPXWK 1OB 1OC 3SF F01 F00 NF~ BRXPI MXMAN WRC AFVGU F04 ADZMN 8UM ABCUV N05 N04 ADDAD WJL ~WT 8-0 8-1 P4A 8-3 AGJLS 8-4 P4B 8-5 P4D IX1 BHBCM LITHE SAMSI J0M MXSTM DRFUL D-6 D-7 33P Q.N 05W XV2 AAESR LOXES MRFUL D-F D-E AIACR CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | December 2011 |
PublicationDateYYYYMMDD | 2011-12-01 |
PublicationDate_xml | – month: 12 year: 2011 text: December 2011 |
PublicationDecade | 2010 |
PublicationPlace | Hoboken |
PublicationPlace_xml | – name: Hoboken – name: Hoboken, NJ – name: United States |
PublicationTitle | Environmental and molecular mutagenesis |
PublicationTitleAlternate | Environ. Mol. Mutagen |
PublicationYear | 2011 |
Publisher | Wiley Subscription Services, Inc., A Wiley Company Wiley-Liss |
Publisher_xml | – name: Wiley Subscription Services, Inc., A Wiley Company – name: Wiley-Liss |
References | Miura D,Dobrovolsky VN,Kimoto T,Kasahara Y,Heflich RH. 2009. Accumulation and persistence of Pig-A mutant peripheral red blood cells following treatment of rats with single and split doses of N-ethyl-N-nitrosourea. Mutat Res 677(1-2): 86-92. Suzuki H,Shirotori T,Hayashi M. 2004. A liver micronucleus assay using young rats exposed to diethylnitrosamine: Methodological establishment and evaluation. Cytogenet Genome Res 104(1-4): 299-303. Gocke E,Ballantyne M,Whitwell J,Muller L. 2009. MNT and MutaMouse studies to define the in vivo dose response relations of the genotoxicity of EMS and ENU. Toxicol Lett 190: 286-297. Gocke E,Wall M. 2009. In vivo genotoxicity of EMS: Statistical assessment of the dose response curves. Toxicol Lett 190: 298-302. Jansen JG,Vrieling H,van Teijlingen CM,Mohn GR,Tates AD,van Zeeland AA. 1995. Marked differences in the role of O6-alkylguanine in hprt mutagenesis in T-lymphocytes of rats exposed in vivo to ethylmethanesulfonate, N-(2-hydroxyethyl)-N-nitrosourea, or N-ethyl-N-nitrosourea. Cancer Res 55: 1875-1882. Bhalli JA,Shaddock JG,Pearce MG,Dobrovolsky VN,Cao X,Heflich RH,Vohr H-W. 2011. Report on Stage III Pig-a mutations assays using benzo[a]pyrene. Environ Mol Mutagenesis, 52: 731-737. Coffing S,Engel M,Dickinson D,Thiffeault C,Spellman R,Shutsky T,Schuler M. 2011. The rat gut micronucleus assay: A good choice for alternative in vivo genetic toxicology testing strategies. Environ Mol Mutagen 52: 269-279. Bryce SM,Bemis JC,Dertinger SD. 2008. In vivo mutation assay based on the endogenous Pig-a locus. Environ Mol Mutagen 49: 256-264. Muller L,Gocke E,Lave T,Pfister T. 2009. Ethyl methanesulfonate toxicity in Viracept-A comprehensive human risk assessment based on threshold data for genotoxicity. Toxicol Lett 190: 317-329. Dertinger SD,Phonethepswath S,Franklin D,Weller P,Torous DK,Bryce SM,Avlasevich S,Bemis JC,Hyrien O,Palis J,MacGregor JT. 2010. Integration of mutation and chromosomal damage endpoints into 28-day repeat dose toxicology studies. Toxicol Sci 115: 401-411. Fenech M. 2000. The in vitro micronucleus technique. Mutat Res 455(1-2): 81-95. Phonethepswath S,Franklin D,Torous DK,Bryce SM,Bemis JC,Raja S,Avlasevich S,Weller P,Hyrien O,Palis J,Macgregor JT,Dertinger SD. 2010. Pig-a mutation: Kinetics in rat erythrocytes following exposure to five prototypical mutagens. Toxicol Sci 114: 59-70. Doak SH,Jenkins GJ,Johnson GE,Quick E,Parry EM,Parry JM. 2007. Mechanistic influences for mutation induction curves after exposure to DNA-reactive carcinogens. Cancer Res 67: 3904-3911. Lovell DP,Omori T. 2008. Statistical issues in the use of the comet assay. Mutagenesis 23: 171-182. Suzuki T,Hayashi M,Wang X,Yamamoto K,Ono T,Myhr BC,Sofuni T. 1997. A comparison of the genotoxicity of ethylnitrosourea and ethyl methanesulfonate in lacZ transgenic mice (Muta Mouse). Mutat Res 395: 75-82. Takasawa H,Suzuki H,Ogawa I,Shimada Y,Kobayashi K,Terashima Y,Matsumoto H,Aruga C,Oshida K,Ohta R,Imamura T,Miyazaki A,Kawabata M,Minowa S,Hayashi M. 2010. Evaluation of a liver micronucleus assay in young rats (III): A study using nine hepatotoxicants by the Collaborative Study Group for the Micronucleus Test (CSGMT)/Japanese Environmental Mutagen Society (JEMS)-Mammalian Mutagenicity Study Group (MMS). Mutat Res 698(1-2): 30-37. Bowen DE,Whitwell JH,Lillford L,Henderson D,Kidd D,Mc Garry S,Pearce G,Beevers C,Kirkland DJ. 2011. Evaluation of a multi-endpoint assay in rats, combining the bone-marrow micronucleus test, the Comet assay and the flow-cytometric peripheral blood micronucleus test. Mutat Res 722: 7-19. Dobo KL,Fiedler RD,Gunther WC,Thiffeault CJ,Cammerer Z,Coffing SL,Shutsky T,Schuler M. 2011. Defining EMS and ENU dose-response relationships using the pig-a mutation assay in rats. Mutat Res 725:13-21. Miura D,Dobrovolsky VN,Mittelstaedt RA,Kasahara Y,Katsuura Y,Heflich RH. 2008. Development of an in vivo gene mutation assay using the endogenous Pig-A gene. II. Selection of Pig-A mutant rat spleen T-cells with proaerolysin and sequencing Pig-A cDNA from the mutants. Environ Mol Mutagen 49: 622-630. Conover WJ,Iman RL. 1982. Analysis of covariance using the rank transformation. Biometrics 38: 715-724. 1982; 38 2011; 725 2004; 104 2011; 722 2009; 190 2000; 455 2010; 114 1997; 395 2010; 115 2010; 698 2008; 49 1995; 55 2011; 52 2008; 23 2007; 67 2009; 677 e_1_2_6_21_1 e_1_2_6_10_1 e_1_2_6_20_1 e_1_2_6_9_1 e_1_2_6_8_1 e_1_2_6_19_1 e_1_2_6_5_1 e_1_2_6_4_1 e_1_2_6_7_1 e_1_2_6_6_1 e_1_2_6_14_1 e_1_2_6_3_1 e_1_2_6_11_1 Jansen JG (e_1_2_6_13_1) 1995; 55 e_1_2_6_2_1 e_1_2_6_12_1 e_1_2_6_17_1 e_1_2_6_18_1 e_1_2_6_15_1 e_1_2_6_16_1 |
References_xml | – reference: Coffing S,Engel M,Dickinson D,Thiffeault C,Spellman R,Shutsky T,Schuler M. 2011. The rat gut micronucleus assay: A good choice for alternative in vivo genetic toxicology testing strategies. Environ Mol Mutagen 52: 269-279. – reference: Conover WJ,Iman RL. 1982. Analysis of covariance using the rank transformation. Biometrics 38: 715-724. – reference: Jansen JG,Vrieling H,van Teijlingen CM,Mohn GR,Tates AD,van Zeeland AA. 1995. Marked differences in the role of O6-alkylguanine in hprt mutagenesis in T-lymphocytes of rats exposed in vivo to ethylmethanesulfonate, N-(2-hydroxyethyl)-N-nitrosourea, or N-ethyl-N-nitrosourea. Cancer Res 55: 1875-1882. – reference: Dobo KL,Fiedler RD,Gunther WC,Thiffeault CJ,Cammerer Z,Coffing SL,Shutsky T,Schuler M. 2011. Defining EMS and ENU dose-response relationships using the pig-a mutation assay in rats. Mutat Res 725:13-21. – reference: Suzuki T,Hayashi M,Wang X,Yamamoto K,Ono T,Myhr BC,Sofuni T. 1997. A comparison of the genotoxicity of ethylnitrosourea and ethyl methanesulfonate in lacZ transgenic mice (Muta Mouse). Mutat Res 395: 75-82. – reference: Gocke E,Wall M. 2009. In vivo genotoxicity of EMS: Statistical assessment of the dose response curves. Toxicol Lett 190: 298-302. – reference: Phonethepswath S,Franklin D,Torous DK,Bryce SM,Bemis JC,Raja S,Avlasevich S,Weller P,Hyrien O,Palis J,Macgregor JT,Dertinger SD. 2010. Pig-a mutation: Kinetics in rat erythrocytes following exposure to five prototypical mutagens. Toxicol Sci 114: 59-70. – reference: Gocke E,Ballantyne M,Whitwell J,Muller L. 2009. MNT and MutaMouse studies to define the in vivo dose response relations of the genotoxicity of EMS and ENU. Toxicol Lett 190: 286-297. – reference: Lovell DP,Omori T. 2008. Statistical issues in the use of the comet assay. Mutagenesis 23: 171-182. – reference: Suzuki H,Shirotori T,Hayashi M. 2004. A liver micronucleus assay using young rats exposed to diethylnitrosamine: Methodological establishment and evaluation. Cytogenet Genome Res 104(1-4): 299-303. – reference: Bhalli JA,Shaddock JG,Pearce MG,Dobrovolsky VN,Cao X,Heflich RH,Vohr H-W. 2011. Report on Stage III Pig-a mutations assays using benzo[a]pyrene. Environ Mol Mutagenesis, 52: 731-737. – reference: Doak SH,Jenkins GJ,Johnson GE,Quick E,Parry EM,Parry JM. 2007. Mechanistic influences for mutation induction curves after exposure to DNA-reactive carcinogens. Cancer Res 67: 3904-3911. – reference: Takasawa H,Suzuki H,Ogawa I,Shimada Y,Kobayashi K,Terashima Y,Matsumoto H,Aruga C,Oshida K,Ohta R,Imamura T,Miyazaki A,Kawabata M,Minowa S,Hayashi M. 2010. Evaluation of a liver micronucleus assay in young rats (III): A study using nine hepatotoxicants by the Collaborative Study Group for the Micronucleus Test (CSGMT)/Japanese Environmental Mutagen Society (JEMS)-Mammalian Mutagenicity Study Group (MMS). Mutat Res 698(1-2): 30-37. – reference: Fenech M. 2000. The in vitro micronucleus technique. Mutat Res 455(1-2): 81-95. – reference: Miura D,Dobrovolsky VN,Kimoto T,Kasahara Y,Heflich RH. 2009. Accumulation and persistence of Pig-A mutant peripheral red blood cells following treatment of rats with single and split doses of N-ethyl-N-nitrosourea. Mutat Res 677(1-2): 86-92. – reference: Muller L,Gocke E,Lave T,Pfister T. 2009. Ethyl methanesulfonate toxicity in Viracept-A comprehensive human risk assessment based on threshold data for genotoxicity. Toxicol Lett 190: 317-329. – reference: Miura D,Dobrovolsky VN,Mittelstaedt RA,Kasahara Y,Katsuura Y,Heflich RH. 2008. Development of an in vivo gene mutation assay using the endogenous Pig-A gene. II. Selection of Pig-A mutant rat spleen T-cells with proaerolysin and sequencing Pig-A cDNA from the mutants. Environ Mol Mutagen 49: 622-630. – reference: Bowen DE,Whitwell JH,Lillford L,Henderson D,Kidd D,Mc Garry S,Pearce G,Beevers C,Kirkland DJ. 2011. Evaluation of a multi-endpoint assay in rats, combining the bone-marrow micronucleus test, the Comet assay and the flow-cytometric peripheral blood micronucleus test. Mutat Res 722: 7-19. – reference: Bryce SM,Bemis JC,Dertinger SD. 2008. In vivo mutation assay based on the endogenous Pig-a locus. Environ Mol Mutagen 49: 256-264. – reference: Dertinger SD,Phonethepswath S,Franklin D,Weller P,Torous DK,Bryce SM,Avlasevich S,Bemis JC,Hyrien O,Palis J,MacGregor JT. 2010. Integration of mutation and chromosomal damage endpoints into 28-day repeat dose toxicology studies. Toxicol Sci 115: 401-411. – volume: 722 start-page: 7 year: 2011 end-page: 19 article-title: Evaluation of a multi‐endpoint assay in rats, combining the bone‐marrow micronucleus test, the Comet assay and the flow‐cytometric peripheral blood micronucleus test publication-title: Mutat Res – volume: 52 start-page: 731 year: 2011 end-page: 737 article-title: Report on Stage III mutations assays using benzo[ ]pyrene publication-title: Environ Mol Mutagenesis – volume: 190 start-page: 298 year: 2009 end-page: 302 article-title: In vivo genotoxicity of EMS: Statistical assessment of the dose response curves publication-title: Toxicol Lett – volume: 23 start-page: 171 year: 2008 end-page: 182 article-title: Statistical issues in the use of the comet assay publication-title: Mutagenesis – volume: 190 start-page: 286 year: 2009 end-page: 297 article-title: MNT and MutaMouse studies to define the in vivo dose response relations of the genotoxicity of EMS and ENU publication-title: Toxicol Lett – volume: 455 start-page: 81 issue: 1–2 year: 2000 end-page: 95 article-title: The in vitro micronucleus technique publication-title: Mutat Res – volume: 190 start-page: 317 year: 2009 end-page: 329 article-title: Ethyl methanesulfonate toxicity in Viracept—A comprehensive human risk assessment based on threshold data for genotoxicity publication-title: Toxicol Lett – volume: 725 start-page: 13 year: 2011 end-page: 21 article-title: Defining EMS and ENU dose‐response relationships using the pig‐a mutation assay in rats publication-title: Mutat Res – volume: 115 start-page: 401 year: 2010 end-page: 411 article-title: Integration of mutation and chromosomal damage endpoints into 28‐day repeat dose toxicology studies publication-title: Toxicol Sci – volume: 49 start-page: 256 year: 2008 end-page: 264 article-title: In vivo mutation assay based on the endogenous Pig‐a locus publication-title: Environ Mol Mutagen – volume: 67 start-page: 3904 year: 2007 end-page: 3911 article-title: Mechanistic influences for mutation induction curves after exposure to DNA‐reactive carcinogens publication-title: Cancer Res – volume: 49 start-page: 622 year: 2008 end-page: 630 article-title: Development of an in vivo gene mutation assay using the endogenous Pig‐A gene. II. Selection of Pig‐A mutant rat spleen T‐cells with proaerolysin and sequencing Pig‐A cDNA from the mutants publication-title: Environ Mol Mutagen – volume: 55 start-page: 1875 year: 1995 end-page: 1882 article-title: Marked differences in the role of O6‐alkylguanine in hprt mutagenesis in T‐lymphocytes of rats exposed in vivo to ethylmethanesulfonate, N‐(2‐hydroxyethyl)‐N‐nitrosourea, or N‐ethyl‐N‐nitrosourea publication-title: Cancer Res – volume: 677 start-page: 86 issue: 1–2 year: 2009 end-page: 92 article-title: Accumulation and persistence of Pig‐A mutant peripheral red blood cells following treatment of rats with single and split doses of N‐ethyl‐N‐nitrosourea publication-title: Mutat Res – volume: 38 start-page: 715 year: 1982 end-page: 724 article-title: Analysis of covariance using the rank transformation publication-title: Biometrics – volume: 104 start-page: 299 issue: 1–4 year: 2004 end-page: 303 article-title: A liver micronucleus assay using young rats exposed to diethylnitrosamine: Methodological establishment and evaluation publication-title: Cytogenet Genome Res – volume: 395 start-page: 75 year: 1997 end-page: 82 article-title: A comparison of the genotoxicity of ethylnitrosourea and ethyl methanesulfonate in lacZ transgenic mice (Muta Mouse) publication-title: Mutat Res – volume: 114 start-page: 59 year: 2010 end-page: 70 article-title: Pig‐a mutation: Kinetics in rat erythrocytes following exposure to five prototypical mutagens publication-title: Toxicol Sci – volume: 52 start-page: 269 year: 2011 end-page: 279 article-title: The rat gut micronucleus assay: A good choice for alternative in vivo genetic toxicology testing strategies publication-title: Environ Mol Mutagen – volume: 698 start-page: 30 issue: 1–2 year: 2010 end-page: 37 article-title: Evaluation of a liver micronucleus assay in young rats (III): A study using nine hepatotoxicants by the Collaborative Study Group for the Micronucleus Test (CSGMT)/Japanese Environmental Mutagen Society (JEMS)‐Mammalian Mutagenicity Study Group (MMS) publication-title: Mutat Res – ident: e_1_2_6_17_1 doi: 10.1016/j.toxlet.2009.04.003 – ident: e_1_2_6_21_1 doi: 10.1016/j.mrgentox.2010.02.009 – ident: e_1_2_6_11_1 doi: 10.1016/j.toxlet.2009.03.021 – ident: e_1_2_6_9_1 doi: 10.1016/j.mrgentox.2011.06.005 – volume: 55 start-page: 1875 year: 1995 ident: e_1_2_6_13_1 article-title: Marked differences in the role of O6‐alkylguanine in hprt mutagenesis in T‐lymphocytes of rats exposed in vivo to ethylmethanesulfonate, N‐(2‐hydroxyethyl)‐N‐nitrosourea, or N‐ethyl‐N‐nitrosourea publication-title: Cancer Res – ident: e_1_2_6_18_1 doi: 10.1093/toxsci/kfp289 – ident: e_1_2_6_2_1 doi: 10.1016/j.mrgentox.2011.02.009 – ident: e_1_2_6_4_1 doi: 10.1002/em.20379 – ident: e_1_2_6_16_1 doi: 10.1002/em.20413 – ident: e_1_2_6_8_1 doi: 10.1158/0008-5472.CAN-06-4061 – ident: e_1_2_6_19_1 doi: 10.1159/000077506 – ident: e_1_2_6_14_1 doi: 10.1093/mutage/gen015 – ident: e_1_2_6_20_1 doi: 10.1016/S1383-5718(97)00144-7 – ident: e_1_2_6_3_1 doi: 10.1002/em.20675 – ident: e_1_2_6_15_1 doi: 10.1016/j.mrgentox.2009.05.014 – ident: e_1_2_6_6_1 doi: 10.2307/2530051 – ident: e_1_2_6_10_1 doi: 10.1016/S0027-5107(00)00065-8 – ident: e_1_2_6_5_1 doi: 10.1002/em.20616 – ident: e_1_2_6_12_1 doi: 10.1016/j.toxlet.2009.03.008 – ident: e_1_2_6_7_1 doi: 10.1093/toxsci/kfq070 |
SSID | ssj0011492 |
Score | 2.1633604 |
Snippet | N‐Ethyl‐N‐nitrosourea (ENU) was evaluated as part of the Stage III trial for the rat Pig‐a gene mutation assay. Groups of six‐ to eight‐week‐old male Sprague... N ‐Ethyl‐ N ‐nitrosourea (ENU) was evaluated as part of the Stage III trial for the rat Pig‐a gene mutation assay. Groups of six‐ to eight‐week‐old male... N-Ethyl-N-nitrosourea (ENU) was evaluated as part of the Stage III trial for the rat Pig-a gene mutation assay. Groups of six- to eight-week-old male Sprague... |
SourceID | proquest pubmed pascalfrancis crossref wiley istex |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 721 |
SubjectTerms | Animals Biological and medical sciences Calibration CD59 CD59 Antigens - genetics Colon - drug effects Colon - ultrastructure comet assay Comet Assay - methods Comet Assay - standards Data Interpretation, Statistical Diethylnitrosamine - toxicity Dose-Response Relationship, Drug Endpoint Determination Erythrocytes - drug effects Erythrocytes - ultrastructure Flow Cytometry Fundamental and applied biological sciences. Psychology gene mutation Genetics of eukaryotes. Biological and molecular evolution Hprt Liver - drug effects Liver - ultrastructure Male Medical sciences Membrane Proteins - genetics micronucleus assay Micronucleus Tests - methods Micronucleus Tests - standards Mutagenicity Tests - methods Mutagenicity Tests - standards Mutagens - toxicity Mutation Organ Specificity Rats Rats, Inbred F344 Rats, Sprague-Dawley Reference Standards Reproducibility of Results reticulocytes Reticulocytes - drug effects Reticulocytes - ultrastructure Species Specificity Spleen - drug effects Spleen - ultrastructure Time Factors Toxicology |
Title | Report on stage III Pig-a mutation assays using N-ethyl-N-nitrosourea - comparison with other in vivo genotoxicity endpoints |
URI | https://api.istex.fr/ark:/67375/WNG-4X7B28V3-T/fulltext.pdf https://onlinelibrary.wiley.com/doi/abs/10.1002/em.20686 https://www.ncbi.nlm.nih.gov/pubmed/22167886 https://www.proquest.com/docview/1028023245 https://www.proquest.com/docview/911935126 |
Volume | 52 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnZ1Lb9QwEICtqhUSF2h5LtDKSAhOKVnHdpIjoD4WqSuEWlhOluM4q6htUjXZquXUE2ck_mF_SWfsTWBRKyFOWWknijMZez7b4xlCXmERkcRKHdhQmIBbieNgxINYW1aIQkYmwQPOe2O5e8A_TsRkiSTdWRifH6JfcMOe4cZr7OA6a-b7-uytxVPkMsFc2xiohTT0uc8bBYzvqiGH4IwDKVPWZZ3948YFP7SCKj3HuEjdgGoKX9PiJuhcZFjnhLbvk29d833syeHmrM02zfe_Mjv-z_utkntzMqXvvCmtkSVbPSB3fK3Ki4fkh0d1WlcUgHJq6Wg0op_K6dXlT02PZ35HnwKK64uGYjT9lI7hPwuGcARX_A2jB-iixjh4enX5i5q-BiLF5WDqDoPRsqJn5VlNMXtsW5-XBuYJ1Fb5SV1WbfOIHGxv7X_YDeZFHALD2VAGcZ7mUZJHWWS4BDiJ5VCnocjCAlEuB2AFoDIyg3kq1yy1Q3SYGWNapEWR5XH0mCxXdWWfEiphtlVkoWQ5HwJHmiQsAE9hysi5YHnMB-RN90mVmWc4x0IbR8rnZmbKHiun1QF52Uue-KweN8i8dlbRC-jTQ4yCi4X6Ot5RfBK_Z8mXSO0PyMaC2fQ3MMG4iEMGT-vsSEHnxR0ZXdl61iikuxCZVgwIvUUGvFEaAZZBg554G_z9AFBwnLimOku69V3U1p67PvtXwefkrls8d3E7L8hyezqz60Bfbbbheto1DIkt1Q |
linkProvider | Wiley-Blackwell |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Report+on+stage+III+Pig-a+mutation+assays+using+N-ethyl-N-nitrosourea+-+comparison+with+other+in+vivo+genotoxicity+endpoints&rft.jtitle=Environmental+and+molecular+mutagenesis&rft.au=Cammerer%2C+Zoryana&rft.au=Bhalli%2C+Javed+A&rft.au=Cao%2C+Xuefei&rft.au=Coffing%2C+Stephanie+L&rft.date=2011-12-01&rft.issn=0893-6692&rft.eissn=1098-2280&rft.volume=52&rft.issue=9&rft.spage=721&rft.epage=730&rft_id=info:doi/10.1002%2Fem.20686&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0893-6692&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0893-6692&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0893-6692&client=summon |